Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)




SCHEDULE 13D/A 0001493152-23-021668 0001517387 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 06/26/2025 false 0001433607 45779A846 InspireMD, Inc. 6303 Waterford District Drive Suite 215 Miami FL 33126 Craig Shore (888) 776-6804 4 Menorat Hamaor St. Tel Aviv L3 6744832 0001517387 N Craig Shore OO N L3 1484505.00 0.00 1484505.00 0.00 1484505.00 N 3.5 IN Consists of (i) 1,066,799 shares of common stock, $0.0001 par value per share (the "Shares") and (ii) options to purchase 417,706 Shares that are currently exercisable or exercisable within 60 days of the reporting date. Based upon 41,720,662 Shares issued and outstanding as of August 4, 2025, which amount was provided reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission on August 4, 2025. Common Stock, $0.0001 par value per share InspireMD, Inc. 6303 Waterford District Drive Suite 215 Miami FL 33126 This statement is filed by Craig Shore. The principal business address of the Reporting Person is 4 Menorat Hamaor St., Tel Aviv, Israel 6744832. The Reporting Person is retired. The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). The Reporting Person has not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. The Reporting Person is a citizen of Israel and the United States. The Reporting Person owns other Shares and option to purchase Shares that have been granted to the Reporting Person pursuant to the InspireMD, Inc. 2013 Long-Term Incentive Plan and the InspireMD, Inc. 2021 Equity Incentive Plan. The Reporting Person has the sole power to vote and dispose of such Shares. Item 3 above is hereby incorporated into this Item 4 by reference. As of the date hereof, the Reporting Person in his individual capacity does not have any present plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of Item 4 to Schedule 13D. The Reporting Person may, at any time and from time to time, (i) review or reconsider his position in the Issuer or change his purpose or formulate plans or proposals with respect thereto or (ii) propose or consider one or more of the actions described in clauses (a) through (j) of Item 4 to Schedule 13D. From time to time, the Reporting Person may also acquire beneficial ownership of additional Shares or other securities of the Issuer, or dispose of some or all of the Shares beneficially owned by the Reporting Person in the open market or in privately negotiated transactions on such terms and at such times as the Reporting Person may deem advisable. The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the footnotes thereto) is incorporated by reference herein. The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the footnotes thereto) is incorporated by reference herein. No transactions in the Issuer's Shares were effected during the past 60 days by the Reporting Person except as set forth in Item 3 above. Except for the Shares listed in row 9 - Sole Dispositive, persons other than the Reporting Person have the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares listed in row 10 - Shared Dispositive Power. The information set forth under Item 3 above and Item 6 of this Schedule 13D is hereby incorporated by reference. 06/26/2025 Craig Shore /s/ Craig Shore Craig Shore 10/29/2025